IP Library Granted Patent US 12,458,787
Granted Patent B2
US 12,458,787 · App. 17/885,999 · Granted Nov 4, 2025

Medical device cap for drug transfer assembly

Inventor: Tushar R. Sathe (Cedar Knolls, NJ)
Assignee: Becton, Dickinson and Company
A61M39/20A61M2205/3561A61M2205/3592A61M2205/6054A61M2205/6063A61M2205/6072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,787
App. No.
17/885,999
Granted
Nov 4, 2025
Kind
B2
Abstract

A medical device cap that protectively surrounds a medical device component for disinfection purposes and includes an identification element that can record and transmit pertinent information of the medical device cap and the medical device component is disclosed. The medical device cap enables documentation of instances when the cap is used and promotes stronger compliance with the use of medical device caps for applications involving disinfection of a medical device component such as an IV access port or a luer tip. Use of the medical device cap results in better compliance and monitoring of the use of such caps and leads to reduced incidence of CRBSI infections related to medical device component contamination. In one embodiment, the medical device cap enables automated real-time electronic documentation of when the cap is applied, while also documenting duration of application and tracking of device for inventory management.

Claims (25)

1 . A method, comprising:

connecting an IV access port cap for a drug transfer assembly to an IV access port of the drug transfer assembly, wherein the IV access port cap includes a cap body removably connectable with the IV access port via an interference fit connection that secures the cap body and the IV access port directly together by a friction force therebetween after insertion of the IV access port into the cap body, an identification element disposed on the cap body, and a disinfecting sponge disposed inside the cap body and including at least one cleaning or disinfecting agent that is released to contact the IV access port when the IV access port is inserted into the cap body to form the interference fit connection that secures the cap body and the IV access port directly together, and wherein the identification element contains a unique identifier associated with the IV access port cap;

reading, with a scanner that resides separately from the drug transfer assembly including the IV access port, when the IV access port cap is connected to the IV access port, the unique identifier associated with the IV access port cap from the identification element to record when the IV access port cap is connected to the IV access port;

removing the IV access port cap from the IV access port; and

reading, with the scanner that resides separately from the drug transfer assembly including the IV access port, when the IV access port cap is removed from the IV access port, the unique identifier associated with the IV access port cap from the identification element to record a duration of time that the cap body is connected to the IV access port for a disinfectant application and a frequency that the cap body is disconnected from the IV access port for the disinfection application.

2 . The method of claim 1 , wherein with the cap body connected to the IV access port, the cap body protectively surrounds at least a portion of the IV access port.

3 . The method of claim 1 , wherein the identification element comprises a barcode.

4 . The method of claim 3 , wherein the barcode is disposed on a cap exterior wall of the cap body.

5 . The method of claim 1 , wherein the identification element comprises an RFID.

6 . A method, comprising:

connecting a medical device cap for a drug transfer assembly to a luer tip of the drug transfer assembly, wherein the medical device cap includes a cap body removably connectable with the luer tip via an interference fit connection that secures the cap body and the luer tip directly together by a friction force therebetween after insertion of the luer tip into the cap body, an identification element disposed on the cap body, and a disinfecting sponge disposed inside the cap body and including at least one cleaning or disinfecting agent that is released to contact the luer tip when the luer tip is inserted into the cap body to form the interference fit connection that secures the cap body and the luer tip directly together, and wherein the identification element contains a unique identifier associated with the medical device cap;

reading, with a scanner that resides separately from the drug transfer assembly including the luer tip, when the medical device cap is connected to the luer tip, the unique identifier associated with the medical device cap from the identification element to record when the medical device cap is connected to the luer tip;

removing the medical device cap from the luer tip; and

reading, with the scanner that resides separately from the drug transfer assembly including the luer tip, when the medical device cap is removed from the luer tip, the unique identifier associated with the medical device cap from the identification element to record a duration of time that the cap body is connected to the luer tip for a disinfection application and a frequency that the cap body is disconnected from the luer tip for the disinfection application.

7 . The method of claim 6 , wherein with the cap body connected to the luer tip, the cap body protectively surrounds at least a portion of the luer tip.

8 . The method of claim 6 , wherein the identification element comprises a barcode.

9 . The method of claim 8 , wherein the barcode is disposed on a cap exterior wall of the cap body.

10 . The method of claim 6 , wherein the identification element comprises an RFID.

11 . A system, comprising:

an IV access port cap for a drug transfer assembly configured to be connected to an IV access port of the drug transfer assembly, wherein the IV access port cap includes a cap body removably connectable with the IV access port via an interference fit connection that secures the cap body and the IV access port directly together by a friction force therebetween after insertion of the IV access port into the cap body, an identification element disposed on the cap body, and a disinfecting sponge disposed inside the cap body and including at least one cleaning or disinfecting agent that is released to contact the IV access port when the IV access port is inserted into the cap body to form the interference fit connection that secures the cap body and the IV access port directly together, and wherein the identification element contains a unique identifier associated with the IV access port cap; and

a scanner that resides separately from the drug transfer assembly including the IV access port, wherein the scanner is configured to: (i) read, when the IV access port cap is connected to the IV access port, the unique identifier associated with the IV access port cap from the identification element to record when the IV access port cap is connected to the IV access port and (ii) read, when the IV access port cap is removed from the IV access port, the unique identifier associated with the IV access port cap from the identification element to record a duration of time that the cap body is connected to the IV access port for a disinfection application and a frequency that the cap body is disconnected from the IV access port for the disinfection application.

12 . The system of claim 11 , wherein the IV access port cap is configured to be connected to a luer tip of the drug transfer assembly.

13 . The system of claim 11 , wherein the identification element comprises a barcode.

14 . The system of claim 11 , wherein the barcode is disposed on a cap exterior wall of the cap body.

15 . The system of claim 11 , wherein the identification element comprises an RFID.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2022
From: SATHE, TUSHAR R.
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 060821/0355 →
Continuity (4)
Continuation 16508874 · Jul 11, 2019
Continuation 14863593 · Sep 24, 2015
Provisional Application 62057001 · Sep 29, 2014
Related Publication 20220379105A1 · Dec 1, 2022
References Cited (33)
US 4432764A · Lopez · 1984 [cited by applicant]
US 5301843A · Groene · 1994 [cited by examiner]
US 7780794B2 · Rogers et al. · 2010 [cited by applicant]
US 10413716B2 · Sathe · 2019 [cited by applicant]
US 20040008123A1 · Carrender et al. · 2004 [cited by applicant]
US 20040073189A1 · Wyatt et al. · 2004 [cited by applicant]
US 20070112333A1 · Hoang et al. · 2007 [cited by applicant]
US 20070287989A1 · Crawford et al. · 2007 [cited by applicant]
US 20070293818A1 · Stout · 2007 [cited by examiner]
US 20070293822A1 · Crawford · 2007 [cited by examiner]
US 20090028750A1 · Ryan · 2009 [cited by examiner]
US 20090137969A1 · Colantonio et al. · 2009 [cited by applicant]
US 20090257910A1 · Segal · 2009 [cited by applicant]
US 20110044850A1 · Solomon et al. · 2011 [cited by applicant]
US 20110054440A1 · Lewis · 2011 [cited by applicant]
US 20110111794A1 · Bochenko et al. · 2011 [cited by applicant]
US 20110184382A1 · Cady · 2011 [cited by applicant]
US 20120216359A1 · Rogers et al. · 2012 [cited by applicant]
US 20130204227A1 · Bochenko et al. · 2013 [cited by applicant]
US 20140074038A1 · Ivosevic · 2014 [cited by applicant]
US 20140276213A1 · Bochenko · 2014 [cited by examiner]
CN 1911739A · 2007 [cited by applicant]
JP 2009536562A · 2009 [cited by applicant]
JP 2009545399A · 2009 [cited by applicant]
JP 2010184087A · 2010 [cited by applicant]
JP 2012120852A · 2012 [cited by applicant]
JP 2014513569A · 2014 [cited by applicant]
WO 2007134066A2 · 2007 [cited by applicant]
WO 2011056888A2 · 2011 [cited by applicant]
WO 2013130891A1 · 2013 [cited by applicant]
WO 2013130891A8 · 2013 [cited by applicant]
WO 2014138122A2 · 2014 [cited by applicant]
WO 2014145906A2 · 2014 [cited by applicant]